The firms will combine Thermo Fisher's mass spec systems with Evosep's liquid chromatography to develop high-throughput clinical proteomic methods.
Bio-Rad tallied net sales of $551.5 million compared to $500.1 million in Q1 2017, driven by growth in both its Life Science and Clinical Diagnostics businesses.
The guidelines are the first to attempt to specify which drugs are appropriate to test for routinely, guideline authors say.
Using consumer taste ratings, genomics, and metabolomics, researchers are starting to catalog genetic variants behind tasty tomatoes.
Phenomenex, a privately held manufacturer of consumables for the separation sciences, will operate as a standalone business and will retain its brand.
Researchers created a method to identify individual humans using proteins found in hair, correlating single amino acid polymorphisms to non-synonymous SNPs.
Researchers tracked one individual's brain imaging patterns, physical features, blood metabolomics, gene expression, and more.
The firms will share instrument control drivers for chromatographic equipment and expertise to integrate their respective hardware and software.
The company sold the technology and assets to Edge BioSystems as part of an ongoing effort to divest legacy non-core businesses and product lines.
In PLOS this week: ancient steppe bison mitochondrial genome, proteomic study of Sauvignon Blanc grapes, and more.
Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.
CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.
The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.
In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.